Introduction: Women who carry the breast cancer gene (BRCA)1/2 pathogenic variants have a higher lifetime risk of developing ovarian cancer than the general population (BRCA1, 44%; BRCA2, 17%). The gene discussed is BRCA2; the disease is ovarian carcinoma.